A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in treatment-resistant pediatric epilepsy, but evidence for most other uses remains limited, heterogeneous, and not yet mature enough for broad clinical adoption. The authors also warn that poor retail product quality, inaccurate labeling, contaminants, hepatotoxicity risk, and drug interactions are major barriers to safe and effective real-world use.

Dispensaries in the Coachella Valley are reporting increased sales this 420, with a growing number of seniors using cannabis for sleep, pain relief, and relaxat

Cody of thisthat CBD assists Kelsey Fields in smoking a dab of THCa concentrate as they celebrate 4/20, the unofficial holiday of marijuana, at MaryJae Cannabis Dispensary, in Austin, Texas,

The North Carolina legislature needs to pass a law regulating the sale of cannabis, a new council on cannabis wrote in its interim report.

Q&A with Scott Mazza on hemp industry regulation, CBD research, product quality, and what changing federal rules could mean for consumers and businesses.